A recent study published on January 31, 2024, in Nature Aging introduces a potential new drug that could help. Scientists believe this drug can remove harmful “zombie” cells from the liver and slow ...
Hosted on MSN1mon
Melanoma study identifies a mechanism for eliminating harmful cells from cancer treatmentMost importantly, he found differential expression changes that always led to prosurvival adaptation of senescent cells mediated by BCL-XL, an anti-apoptotic protein that prevents the process of ...
News Medical on MSN8d
New drug candidate may help combat metabolic dysfunction-associated steatotic liver diseaseA study published in Nature Aging has revealed a promising new drug candidate that may help combat metabolic dysfunction-associated steatotic liver disease (MASLD), a chronic liver condition that ...
The BCL2 family of proteins, comprising both pro-apoptotic (BAX, BAK) and pro-survival (BCL2, BCL-XL, MCL1 and BCL-W) members, are pivotal players in this process. Protein–protein interactions ...
The groundbreaking study demonstrates drug candidate can safely and effectively target and eliminate senescent cells, also known as “zombie cells,” from the liver.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback